Zobrazeno 1 - 10
of 244
pro vyhledávání: '"J. Michael Dixon"'
Autor:
Arran K. Turnbull, Cigdem Selli, Carlos Martinez-Perez, Anu Fernando, Lorna Renshaw, Jane Keys, Jonine D. Figueroa, Xiaping He, Maki Tanioka, Alison F. Munro, Lee Murphy, Angie Fawkes, Richard Clark, Audrey Coutts, Charles M. Perou, Lisa A. Carey, J. Michael Dixon, Andrew H. Sims
Publikováno v:
BMC Bioinformatics, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background High-throughput transcriptomics has matured into a very well established and widely utilised research tool over the last two decades. Clinical datasets generated on a range of different platforms continue to be deposited in public
Externí odkaz:
https://doaj.org/article/35931cd60eb849c58eee6a74c308610f
Autor:
Cigdem Selli, Arran K. Turnbull, Dominic A. Pearce, Ang Li, Anu Fernando, Jimi Wills, Lorna Renshaw, Jeremy S. Thomas, J. Michael Dixon, Andrew H. Sims
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-15 (2019)
Abstract Background The risk of recurrence for endocrine-treated breast cancer patients persists for many years or even decades following surgery and apparently successful adjuvant therapy. This period of dormancy and acquired resistance is inherentl
Externí odkaz:
https://doaj.org/article/fd063ba684234388a49de0f5201f443c
Autor:
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 4, Pp 823-853 (2024)
Abstract Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, characterized by extensive intratumoral heterogeneity, high metastasis, and chemoresistance, leading to poor clinical outcomes. Despite progress, the mechanis
Externí odkaz:
https://doaj.org/article/f9d72b0bea3548a1b9749e30da03cd30
Publikováno v:
Cancer Research. 83:PD10-09
Background: 80% of all breast cancers (BCs) are ER-positive (ER+). Not all respond to adjuvant endocrine therapy (aET) and a significant number develop endocrine resistance and recur. The basis for primary and acquired endocrine resistance is poorly
Publikováno v:
Renshaw, L, Dixon, M, Anderson, J & Turnbull, A K 2022, ' Mondor’s Disease of the Breast: A cutaneous thromboembolic manifestation of Covid-19? ', The Breast . https://doi.org/10.1016/j.breast.2022.11.006
BackgroundMondor's disease is a rare disorder characterised by thrombosis of superficial veins within the subcutaneous tissue of the breast and other organs. While factors such as trauma, infection, physical exertion, breast cancer and breast surgery
Autor:
Sherene Loi, Stefan Michiels, Jose Baselga, John M S Bartlett, Sandeep K Singhal, Vicky S Sabine, Andrew H Sims, Tarek Sahmoud, J Michael Dixon, Martine J Piccart, Christos Sotiriou
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0216175 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0053292.].
Externí odkaz:
https://doaj.org/article/d71c1eb6584e47cfbf6051eab8cecf7c
Autor:
Anja van de Stolpe, Cornelis J.H. van de Velde, Judith R. Kroep, Wim Verhaegh, J. Michael Dixon, Arran K. Turnbull, Andrew H. Sims, John W.M. Martens, Bart van der Burg, Susan Kloet, Elma Meershoek-Klein Kranenbarg, Sevgi E. Fruytier, Anne van Brussel, Eveline C. den Biezen-Timmermans, Ayoub Charehbili, Peter J.K. Kuppen, Erik J. Blok, Márcia A. Inda
Supplemental methods on estradiol measurements and sample analysis. Supplemental tables: 1. Public datasets used; 2. Estrogen concentrations on breast tissue; 3. Association of baseline parameters and ERPAS (Edinburgh cohort); 4. Logistic regression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50dd21e77f29c9ec8399f858f46f98f9
https://doi.org/10.1158/1535-7163.22510236.v1
https://doi.org/10.1158/1535-7163.22510236.v1
Autor:
Anja van de Stolpe, Cornelis J.H. van de Velde, Judith R. Kroep, Wim Verhaegh, J. Michael Dixon, Arran K. Turnbull, Andrew H. Sims, John W.M. Martens, Bart van der Burg, Susan Kloet, Elma Meershoek-Klein Kranenbarg, Sevgi E. Fruytier, Anne van Brussel, Eveline C. den Biezen-Timmermans, Ayoub Charehbili, Peter J.K. Kuppen, Erik J. Blok, Márcia A. Inda
Endocrine therapy is important for management of patients with estrogen receptor (ER)–positive breast cancer; however, positive ER staining does not reliably predict therapy response. We assessed the potential to improve prediction of response to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b4f06713dad953982cc15f8a6c41e3
https://doi.org/10.1158/1535-7163.c.6539547.v1
https://doi.org/10.1158/1535-7163.c.6539547.v1
Autor:
Arran Turnbull, J. Michael Dixon, Lisa A. Carey, Charles M. Perou, Joel S. Parker, James Meehan, Mark Gray, Charlene Kay, Carlos Martinez-Perez, Lorna Renshaw, Xiaping He, Youli Xia
Supplementary Data from Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37bfbd200f4a48ae4b320c6fa014db22
https://doi.org/10.1158/1078-0432.22488159
https://doi.org/10.1158/1078-0432.22488159
Autor:
Emilio Alba, Charles M. Perou, J. Michael Dixon, Miguel Martín, Eva Carrasco, Mitch Dowsett, Barbara Adamo, Rosalía Caballero, Abdul Aziz Bin Aiderus, Begoña Jimenez, Nuria Ribelles, Joel S. Parker, Laia Paré, Montserrat Muñoz, Arrate Plazaola, Pedro Sánchez-Rovira, José Ignacio Chacón, Angels Arcusa, Juan de la Haba-Rodríguez, Joan Albanell, Lourdes Calvo, Anita K. Dunbier, Arran K. Turnbull, Ana Lluch, Aleix Prat
Supplemental Methods, Tables and Figures Tables Table S1. CES association with chemotherapy sensitivity (measured as pCR) in the MDACC-based dataset. Table S2. CES association with chemotherapy sensitivity (measured as Residual Cancer Burden [RCB]) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071ce3b5b50c3b9e347946f093b37ba6
https://doi.org/10.1158/1078-0432.22463339.v1
https://doi.org/10.1158/1078-0432.22463339.v1